Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
21.68
+0.84 (4.03%)
May 22, 2026, 4:00 PM EDT - Market closed
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $1.42 billion as of May 22, 2026. Its market cap has increased by 98.93% in one year.
Market Cap
1.42B
Enterprise Value
886.15M
1-Year Change
98.93%
Ranking
Category
Stock Price
$21.68
Market Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has increased from $931.70M to $1.42B, an increase of 52.89%. That is a compound annual growth rate of 28.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 1.42B | 54.50% |
| Dec 31, 2025 | 921.98M | -2.74% |
| Dec 31, 2024 | 947.92M | 1.74% |
| Sep 13, 2024 | 931.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MBX Biosciences | 1.52B |
| Novavax | 1.51B |
| Precigen | 1.51B |
| Ardelyx | 1.51B |
| Inhibrx Biosciences | 1.49B |
| Immunocore Holdings | 1.47B |
| SELLAS Life Sciences Group | 1.45B |
| Maze Therapeutics | 1.43B |